AIM weekly movers: Diurnal more than doubles on bid

0

Diurnal (LON: DNL) was the biggest riser on the week with a 139% gain to 26.85p following a cash offer for the company. Neurocrine Biosciences Inc is making a recommended bid of 27.5p a share in cash for Diurnal, which values the drug developer at £48.3m. The April 2021 placing and open offer was at 70p a share and the share price has slumped since then. More cash would need to be raised and that could heavily dilute existing shareholders, so the bid is attractive. Diurnal has two approved treatments. The Alkindi hydrocortisone treatment for paediatric adrenal hyperplasia and Efmody which is a similar treatment for adolescents and adults. Revenues have been slow to build for these treatments.

Digital payments technology provider Bango (LON: BGO) is acquiring the global payments division of NTT DOCOMO for €4m, but this reduces to €900,000 after the cash in the business is taken into account. There will be integration costs and additional overheads taken on. This deal adds new telecoms partners and adds Discovery and Shopify to the client base, as well as enhancing the position with existing clients, such as Netflix. Bango will provide payment services to NTT DOCOMO in Japan. The deal should be earnings enhancing in 2023, when revenues of $16m could be contributed. Less, positive are the $30m-$35m of restructuring charges, transaction costs and write-downs revealed for 2022. That is around the level of the expected income this year. Even so, the share price was 27.2% ahead at 198.5p.

Westminster Security (LON: WSG) is a bit of a yoyo share moving up and down on the latest news. This week a new mass entry screening contract for a theatre and exhibition centre in northern England pushed up the share price by 26.5% to 1.55p.  

Shield Therapeutics (LON: STX) has fallen sharply this year, but stake building helped the share price recover 18% to 10.8p, which is still down by three-quarters this year. AOP Orphan Pharmaceuticals AG, which targets rare diseases, has more than doubled its stake to 27%. Jupiter Fund Management reduced its shareholding from 5.87% to 4.6%. Shield Therapeutics has an approved iron deficiency treatment, but in common with Diurnal it is finding it difficult to build revenues.

==========

Fallers

Fusion Antibodies (LON: FAB) is the worst performer of the week, falling 38.2% to 51p, after the Belfast-based antibody developer released full figures. Annual revenues were ahead of expectations and the loss was flat at £1.3m, but management is cautious about the outlook for its customer base.

The cancellation of a contract by a client in Israel has hit the Ethernity Networks (LON: ENET), which has fallen by 26% to 9.25p. The contract relates to the provision of the company’s Universal Edge Platform. The client claims that its customers have complained about delays in product delivery. Ethernity Networks blames its client for delays due to discussions about pricing and amendments to designs. The contract was worth $930,000 and $107,000 has been invoiced. Last year’s group revenues were $2.64m.

IDE Group Holdings (LON: IDE) has further delayed the publication of its 2021 annual report. The managed services provider believes that the auditors will complete their work by the end of September. The share price fell 25% to 0.9p.

Disappointing drilling results from oil and gas producer and explorer Serinus Energy (LON: SENX) sent the share price 22.2% lower to 10.5p. Arden Partners has reduced is risked NAV from 55p a share to 53p a share. Management says the Canar-1 exploration well in Romania does not justify flow testing. There were signs of residual gas, and it is possible that the gas migrated through this zone. The next well to be drilled is Monfrinu Nord-1. Raising an unsecured convertible loan note facility of up to £750,000 was taken negatively by investors in oil company TomCo Energy (LON: TOM). The cash drawn down has to be paid by the end of November, yet the interest charge is a fixed 5% of the principal drawn down. There will still be a $1.25m loan from Valkor, which is due to be repaid in October. A longer-term solution to financing will need to be found. The share price slipped 20.7% to 0.436p.

FTSE 100 regains ground after turbulent week

0

International markets suffered a turbulent week, with European markets battered by the ongoing energy crisis, US markets bracing for further aggressive interest rate hikes and the FTSE 100 tumbling as the UK faces the worst living standards in a century.

The blue chip index regained some ground after its surprising nosedive earlier this week, closing 1.8% higher at 7,281.1 on Friday. However, the market fell 2.6% over the week, highlighting the tightening screws as the country looked ahead to a difficult winter.

US markets gained on positive jobs data, with the economy marking 315,000 new nonfarm payrolls against analyst expectations of 300,000.

However, news of a continued tightness in the labour market is set to add fuel to the Fed’s hawkish fire, with chair Jerome Powell eyeing a softening in the labour market before he begins to consider a dovish approach to rate hikes.

“US jobs numbers … offer an insight into the health of the world’s largest economy, it is typically influential on markets. However, US Federal Reserve chair Jerome Powell was so clear in his messaging at last week’s Jackson Hole summit that it would take a big surprise to really move the dial,” said AJ Bell investment director Russ Mould.

The NASDAQ rose 1% to 11,908.8, the Dow Jones increased 1% to 31,996.5 and the S&P 500 climbed 1.1% to 4,011.9.

“There will be some relief on Friday morning that, for now, the recent wave of selling in global stock markets has eased,” said Mould.

“After US stocks broke a four-day losing streak overnight, the FTSE 100 has eked out modest gains, supported by a broad range of companies caught up in the sell-off.”

Housebuilders fall

Housebuilders fell to the bottom of the FTSE 100 after Nationwide reported a slowdown in the housing market over August.

Last month saw a 10% annual rise in house prices against an 11% rise in July, and although the figures remained in the double-digits, analysts pointed out signs that the red-hot market was starting to cool.

Surveyors noted a drop in new buyer enquiries in August, with a slide in the level of mortgage approvals to below pre-pandemic numbers.

Berkley Group Holdings shares fell 2.6% to 3,494.5p, Persimmon decreased 1.7% to 1,443.7p and Barratt Developments declined 1.1% to 410.3p.

“Housebuilders were firmly lower after a week which revealed cracks in the foundations of the property market and raised questions about how much longer their selling prices can run ahead of rising labour and raw material costs,” said Mould.

Avast/NortonLifeLock merger greenlit

Avast shares gained 0.2% to 715.3p after the company received the final green light from the Competitions and Markets Authority (CMA) for its merger with NortonLifeLock.

The CMA opened a prior investigation into the merger over concerns the transaction would be harmful to sector competition. However, the deal was cleared by the Authority after a provisional clearance earlier in August.

The agreement was confirmed after the CMA noted sufficient competition in the industry from Microsoft and McAfee, among others.

“Competition authorities cleared the takeover of Avast by rival NortonLifeLock and while this was not a surprise, it adds to a potential exodus of firms from an already threadbare UK tech sector, with Aveva and Micro Focus among those names either already in discussions or rumoured to be attracting interest,” said Mould.

Shell CEO to resign

Shell shares rose 2.2% to 2,324p, despite reports from Reuters that CEO Ben van Beurden was set to resign from the oil giant after almost a decade at the company.

Two sources close to the matter identified four candidates shortlisted to replace the departing boss, with the new CEO to be chosen under a succession committee led by chair Andrew Mackenzie.

Shell head of integrated gas and renewables Wael Sawan is allegedly on the list, along with downstream refining operations head Huibert Vigeveno.

Chief financial officer Sinead Gorman and head of upstream Zoe Yujnovich are also under consideration for the role.

“After yesterday’s surprise departure of Reckitt Benckiser chief executive Laxman Narasimhan, it looks as if another FTSE 100 company is poised for a change at the top as Shell’s Ben van Beurden is reportedly preparing to step down,” said Mould.

“His successor faces a tough task … with regulatory pressure likely to be a key theme. Internal appointments are rumoured to be in the running, befitting an organisation which has often looked inwards when planning a succession process.”

“Whoever prevails will have to balance the demands of the environmental lobby, governments and investors. At least van Beurden spared them the decision of cutting the dividend, a step taken for the first time since the Second World War in 2020. However, there will be more hard decisions to come if the company is going to live up to its net zero rhetoric.”

US bonds enter first bear market in decades

0

Analysts marked an accelerating decline in bond markets, bringing bad news for fixed income investors in an already difficult market environment.

Global bonds have lost a fifth of their value so far in 2022, with the fresh surge on US government bond yields on the back of US Fed chair Jerome Powell’s hawkish stance at the Jackson Hole convention adding to investor concerns.

Across the Atlantic, bonds in several European nations saw their worst monthly performance in decades last month, sparking a move in the Bloomberg Aggregate Bond index down approximately 20% from its peak for the first time in history.

Bonds are recognised as an asset class for typically reliable returns, making the 20% decline a sharp surprise for analysts and signalling a entry into a bear market.

Investors are speculating the weakness in bonds will persist as central banks tighten monetary policy in the fight against surging inflation in the US and internationally.

Experts expect the US Federal Reserve to hike interest rates by an additional 0.5% to 0.75%, following Powell’s hawkish remarks at the Jackson Hole conference in late August.

US Nonfarm Payrolls beat analyst expectations with 315,000 jobs

0

The US added 315,000 nonfarm payrolls in August 2022, representing the smallest job gain since April 2021.

The figure comes after a downwardly revised 526,000 result in July. The report exceeded market forecasts of 300,000 jobs and indicated a remaining tightness in the labour market.

The positive jobs results will boost speculation in the markets about a hawkish US Fed interest rates hike, with chair Jerome Powell citing the tight labour market as a contributing factor to continued aggressive rate hikes from the Reserve.

Sectors with high jobs increases included professional and business services, health care and retail trade.

Although August marked a historically less impressive period for new jobs growth, nonfarm employment is currently 240,000 over the pre-Covid level in February 2020.

Establishing World-Class Assets and Utilising Direct Lithium Extraction with CleanTech Lithium

We were delighted to be joined by Dr Aldo Boitano, CEO of CleanTech Lithium, for a deep dive into lithium markets and CleanTech’s operations in Chile.

Register to hear from CleanTech Lithium at the UK Investor Magazine Virtual Conference 27th September

CleanTech Lithium are developing three assets within the ‘Lithium Triangle’ in Chile and are targeting first production by 2024/25. The Lithium Triangle of Chile, Bolivia and Argentina is thought to hold some 50 million tonnes of lithium and CleanTech are setting about increasing this with additional resources from their lithium brine projects.

CleanTech will employ Direct Lithium Extraction (DLE) techniques across their portfolio. Dr Boitano provides a fascinating overview of DLE efficiencies and the ESG characteristics of DLE lithium production methods.

Aldo breaks down CleanTech Lithium’s portfolio and what investors can expect on the journey to first production.

Register to field questions to CleanTech Lithium at the UK Investor Magazine Virtual Conference 27th September

AIM movers: Shoe Zone buy back and Serinus Energy well disappoints

1

Footwear retailer Shoe Zone (LON: SHOE) is buying back up to £3.5m shares over a period up until the end of November or when the money is spent. Shoe Zone is the best performer on the day with a 15.1% increase to 167.5p a share. This follows further positive trading news earlier in the week. Management raised 2021-22 pre-tax profit guidance from £9.5m to £10.5m.

Property investor Panther Securities (LON: PNS) says that its swap liability position has fallen from £15.3m to £3.9m in the six months to June 2022 and since then it has declined to £400,000. Panther Securities is benefiting from being sheltered from higher interest charges as rates increase. The share price rose 5.45% to 290p.

Sunrise Resource (LON: SRES) says Tolsa has identified multiple sepiolite horizons at the Pioche sepiolite project in Nevada. Tolsa, which is the world’s largest producer of sepiolite, has an option to purchase the project for $1.25m plus an ongoing royalty of 3%. Sepiolite is used in agriculture to carry pesticides and bind animal feed, high temperature drilling muds and pet litters. It is a scarce commodity with a limited number of commercial deposits one of which is in the US. The share price is 7.89% higher at 0.1025p.

Pharma software provider Instem (LON: INS) has gained its largest ever contract that is worth at least $12m over five years. The deal is with a contract research organisation and is for the company’s cloud-based Aspire clinical trial acceleration software, which will be launched with the customer in one year. There is $3m for implementation and the rest is paid in instalments of $2.25m a year over four years. The annual recurring revenues are $1m more than for the Instem system that is being replaced.

Oil and gas producer and explorer Serinus Energy (LON: SENX) says that the results of the Canar-1 exploration well in Romania did not justify flow testing. That sent the shares 22.2% lower at 10.5p. There were signs of residual gas, and it is possible that the gas migrated through this zone. Arden Partners has reduced is risked NAV from 55p a share to 53p a share. The next well to be drilled is Monfrinu Nord-1.

The Competition and Markets Authority (CMA) intends to seek a competition disqualification order against Alliance Pharma (LON: APH) chief executive Peter Butterfield. Alliance Pharma is one of four pharma companies that the CMA says infringed competition law. Alliance Pharma is appealing the decision and a £7.9m fine. The appeal should be heard next year. The investigation related to prochlorperazine and infringement was between June 2013 and July 2018. Alliance Pharma out-licenced prochlorperazine to a distributor in 2013 at a fixed transfer price and says that it did not profit from any market sharing agreement. Last year, the drug generated revenues of £700,000. The share price slumped by 13.6% to 80.8p on the day and it has fallen by one-quarter so far this year.

Pound steadies ahead of PM appointment

The pound Sterling steadied on Friday in advance of the upcoming Prime Minister appointment next week.

The currency took a sharp drop earlier in the week on the back of a report from the Resolution Foundation, which revealed the UK was facing its largest drop in living standards in a century.

The pound fell to its weakest level since the country kicked off Brexit in 2016 following the devastating report.

According to Reuters, some analysts worried the pound could flirt with its lowest record level of approximately $1.05, which it hit in 1985.

Liz Truss currently stands as the front runner in the Prime Ministerial race, anticipated to beat former chancellor Rishi Sunak for the position.

Truss has been called on to bring billions of pounds in urgent support to UK households, in the form of raising benefits in line with inflation and imposing a more reasonable energy price cap to assist families with budget-devouring energy bills set to hit the population in October with an 80% price cap rise to over £3,000 per year on average.

The favourite for leadership has instead tried to push the appeal of tax cuts, however Truss didn’t explain how she intended to fund urgent public services as the country heads into a difficult winter for social services and the struggling NHS.

The pound is currently also contesting with a strong Dollar, as the US Fed looks set to raise interest rates higher following Fed Chair Jerome Powell’s hawkish stance at the Jackson Hole convention in late August, along with expected strong data from the US Nonfarm Payrolls report today, boosting incentive for more aggressive rate hikes in the realm of 0.5%-0.75%.

One pound equated to 1.1564 Dollars and 1.1565 Euros in late morning trading on Friday.

G7 to push forward on Russian oil price cap

G7 finance ministers are reportedly set to shore up plans for a price cap on Russian oil, with the aim of kneecapping Russia’s revenues for its invasion of Ukraine, while maintaining crude flows to avoid additional spikes in price.

The G7 members will be meeting virtually to discuss the implementation of plans to help mitigate the energy crisis storm in Europe, which has seen energy prices skyrocket across the continent.

Details remained unclear, including the per-barrel level of the price cap, above which nations would refuse insurance and finance to crude and oil products shipped from Russia.

UK Finance Minister Nadhim Zahawi commented in Washington on Thursday that he was optimistic minister at the meeting would “have a statement that will mean that we can move forward at pace to deliver this … we want to get this oil price cap over the line.”

Western leaders came to a conclusion in June to discuss a potential price cap to place a limit on the cost refiners and traders would pay for Russian crude. However, Moscow said it would not abide by the decree and could circumvent it by supplying oil to countries not bound under the price agreement.

White House spokesperson Karine Jean-Pierre did not issue comment at the time of writing, and said she did not want “to get ahead of that meeting.”

Dollar strengthens in advance of US Nonfarm Payroll report

The Dollar reached a close to two-decade high in advance of the US nonfarm payrolls report, as markets awaited confirmation of promising jobs data which could advance hopes of a hawkish stance from the US Fed at the next interest rates meeting.

US Fed chair Jerome Powell previously commented at the Jackson Hole convention that a tight labour market was one of the factors boosting the organisation’s movement towards continued aggressive rate hikes, with the Fed aiming for a softening in the labour market to tackle spiking inflation, which currently stands at 8.5% in the US.

Analysts are currently estimating a 300,000 jobs growth in August, adding to the stretch of positive employment data over the past couple of months for the States.

One Pound equated to 1.1567 Dollars and one Euro equated to 0.9991 Dollars in late morning trading on Friday.

Shell CEO Ben van Beurden to resign, says Reuters

0

Shell CEO Ben van Beurden is set to resign after almost a decade in the position, according to Reuters.

Two sources close to the matter apparently told the news organisation van Beurden had shortlisted four potential candidates to replace him in the leadership role.

Shell head of integrated gas and renewables Wael Sawan is said to have made the list, along with head of downstream refining operations Huibert Vigeveno.

Chief financial officer Sinead Gorman and upstream head Zoe Yujnovich round out the final options for the CEO role.

Reuters said Shell’s board succession committee led by Chairman Andrew Mackenzie had met several times over the last few months to discuss plans for van Beurden’s leave from the company.

Van Beurden joins Reckitt Benckiser CEO Laxman Narasimhan in the exodus of FTSE 100 CEOs over 2022, with the Shell boss representing the 18th leader to jump ship so far in the volatile market environment.

“After yesterday’s surprise departure of Reckitt Benckiser chief executive Laxman Narasimhan, it looks as if another FTSE 100 company is poised for a change at the top as Shell’s Ben van Beurden is reportedly preparing to step down,” said AJ Bell investment director Russ Mould.

“While there has been considerable volatility in the interim, ultimately since van Beurden took over at the beginning of 2014 he has delivered a total return to shareholders of 45.1%. Given this period encompassed an oil price crash very early in his tenure and a global pandemic, this is not too shabby.”

“Whoever prevails will have to balance the demands of the environmental lobby, governments and investors. At least van Beurden spared them the decision of cutting the dividend, a step taken for the first time since the Second World War in 2020. However, there will be more hard decisions to come if the company is going to live up to its net zero rhetoric.”

Shell declined to comment on the article at the time of writing.